These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 17872962)
21. Apo- and holo- transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier. Baringer S; Palsa K; Simpson IA; Connor JR Res Sq; 2023 Jan; ():. PubMed ID: 36711476 [No Abstract] [Full Text] [Related]
22. Apo- and holo- transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier. Baringer SL; Palsa K; Simpson IA; Connor JR bioRxiv; 2023 Jan; ():. PubMed ID: 36712094 [TBL] [Abstract][Full Text] [Related]
23. Ionic residues of human serum transferrin affect binding to the transferrin receptor and iron release. Steere AN; Miller BF; Roberts SE; Byrne SL; Chasteen ND; Smith VC; MacGillivray RT; Mason AB Biochemistry; 2012 Jan; 51(2):686-94. PubMed ID: 22191507 [TBL] [Abstract][Full Text] [Related]
24. Predicting long term cooperativity and specific modulators of receptor interactions in human transferrin from dynamics within a single microstate. Abdizadeh H; Atilgan C Phys Chem Chem Phys; 2016 Mar; 18(11):7916-26. PubMed ID: 26955866 [TBL] [Abstract][Full Text] [Related]
25. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas. Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676 [TBL] [Abstract][Full Text] [Related]
26. Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. Davies PS; Zhang AS; Anderson EL; Roy CN; Lampson MA; McGraw TE; Enns CA Biochem J; 2003 Jul; 373(Pt 1):145-53. PubMed ID: 12667138 [TBL] [Abstract][Full Text] [Related]
27. Evidence that His349 acts as a pH-inducible switch to accelerate receptor-mediated iron release from the C-lobe of human transferrin. Steere AN; Byrne SL; Chasteen ND; Smith VC; MacGillivray RT; Mason AB J Biol Inorg Chem; 2010 Nov; 15(8):1341-52. PubMed ID: 20711621 [TBL] [Abstract][Full Text] [Related]
28. Structural and functional stability of the mature transferrin receptor from human placenta. Orberger G; Fuchs H; Geyer R; Gessner R; Köttgen E; Tauber R Arch Biochem Biophys; 2001 Feb; 386(1):79-88. PubMed ID: 11361003 [TBL] [Abstract][Full Text] [Related]
29. The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding. Wally J; Halbrooks PJ; Vonrhein C; Rould MA; Everse SJ; Mason AB; Buchanan SK J Biol Chem; 2006 Aug; 281(34):24934-44. PubMed ID: 16793765 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy. Ikuta K; Yersin A; Ikai A; Aisen P; Kohgo Y J Mol Biol; 2010 Mar; 397(2):375-84. PubMed ID: 20096706 [TBL] [Abstract][Full Text] [Related]
31. Intracellular interactions of transferrin and its receptor during biosynthesis. Neefjes JJ; Hengeveld T; Tol O; Ploegh HL J Cell Biol; 1990 Oct; 111(4):1383-92. PubMed ID: 2211816 [TBL] [Abstract][Full Text] [Related]
32. Holo-transferrin and thrombin can interact to cause brain damage. Nakamura T; Xi G; Park JW; Hua Y; Hoff JT; Keep RF Stroke; 2005 Feb; 36(2):348-52. PubMed ID: 15637325 [TBL] [Abstract][Full Text] [Related]
33. Transferrin-oligomers as potential carriers in anticancer drug delivery. Lim CJ; Shen WC Pharm Res; 2004 Nov; 21(11):1985-92. PubMed ID: 15587919 [TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Bennett MJ; Lebrón JA; Bjorkman PJ Nature; 2000 Jan; 403(6765):46-53. PubMed ID: 10638746 [TBL] [Abstract][Full Text] [Related]
35. Low affinity of Trypanosoma brucei transferrin receptor to apotransferrin at pH 5 explains the fate of the ligand during endocytosis. Maier A; Steverding D FEBS Lett; 1996 Oct; 396(1):87-9. PubMed ID: 8906872 [TBL] [Abstract][Full Text] [Related]
36. Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors. Khoo TC; Tubbesing K; Rudkouskaya A; Rajoria S; Sharikova A; Barroso M; Khmaladze A Redox Biol; 2020 Sep; 36():101617. PubMed ID: 32863219 [TBL] [Abstract][Full Text] [Related]
37. Immunological study of complex formation between soluble transferrin receptor and transferrin. Kogan A; Filatov V; Gusev N; Bereznikova A; Kolosova O; Katrukha A Am J Hematol; 2005 Aug; 79(4):281-7. PubMed ID: 16044455 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of HFE-induced regulation of iron homeostasis: Insights from the W81A HFE mutation. Zhang AS; Davies PS; Carlson HL; Enns CA Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9500-5. PubMed ID: 12874382 [TBL] [Abstract][Full Text] [Related]
39. Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins. Farnaud S; Amini M; Rapisarda C; Cammack R; Bui T; Drake A; Evans RW; Suryo Rahmanto Y; Richardson DR Int J Biochem Cell Biol; 2008; 40(12):2739-45. PubMed ID: 18691669 [TBL] [Abstract][Full Text] [Related]
40. Nanostructures and molecular force bases of a highly sensitive capacitive immunosensor. Zeng G; Yang P; Zheng Z; Feng Q; Cai J; Zhang S; Chen ZW Proteomics; 2005 Nov; 5(17):4347-53. PubMed ID: 16294312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]